Alterity Therapeutics Announces Board Reshuffle as Chairman and Director Retire
Alterity Therapeutics Ltd. announced board changes with the retirement of Geoffrey Kempler, founding shareholder and Non-Executive Chairman, and Brian Meltzer, Non-Executive Director, ahead of its Annual General Meeting on November 21, 2025. These changes aim to support the company's growth as it moves towards Phase 3 clinical development.
Alterity Therapeutics Ltd. announced upcoming board changes ahead of its Annual General Meeting on 21st November 2025. Geoffrey Kempler, founding shareholder and current Non-Executive Chairman, will retire as Chair and Director. Brian Meltzer will also retire as Non-Executive Director. These changes are intended to support Alterity’s next phase of growth as it advances towards Phase 3 clinical development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alterity Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-113288), on November 21, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
